Skip to content
Medical Health Aged Care, Research Development

Study highlights reasons behind antibiotic use in children in rural and remote NT

Charles Darwin University 2 mins read

Northern Territory mothers living in remote or rural areas often make decisions about the need for antibiotics for their children out of fear or based on the advice of their personal network a new study by Charles Darwin University (CDU) researchers has found.

Lead author and CDU PhD student Stephanie Marsh has explored the factors that contribute to a parent’s decision to give their children antibiotics to learn more about overuse and misuse of antibiotics, a key driver for the acceleration of antimicrobial resistance (AMR).

AMR, which is when micro-organisms such as bacteria and fungi defeat the drugs designed to kill them, is fast becoming an urgent global health threat.

Ms Marsh said as children are amongst the highest recipients of antibiotics, there is a great need for understanding the drivers of parental decisions towards their children’s antibiotic use.

“There is limited information around antibiotic use and the reasons behind it in rural and remote areas in the NT,” Ms Marsh said.

“We need to learn about and understand these behaviours, including those that are less optimal to help find ways to combat AMR.”

For the study, Ms Marsh conducted focus groups with mothers in rural and remote communities across the Territory.

A significant finding from the study revealed that decisions about the use of antibiotics were not always knowledge based and were often driven by fear of serious illness.

“The mothers we spoke with displayed some accurate knowledge that antibiotics treat bacterial infections, which contributed to their general understanding of the role of antibiotic medicines,” Ms Marsh said.

“However, decisions about the use of antibiotics were not always based on knowledge with parental beliefs also guiding opinions and behaviour.”

When making health decisions about the use of antibiotics, participants in the study indicated that they often obtained guidance from others.

“The mothers reported that despite favouring the doctor’s advice when deciding on antibiotic treatment for their child, they also highly valued input from others in their social network, such as friends and family,” Ms Marsh said.

“Whilst they may obtain this advice differently and for varying reasons, nearly all parents reported to seek additional direction from others to alleviate their concerns.”

Interestingly, the study found that mothers are more cautious in their approach towards antibiotics use in infants.

“We saw differences in the findings between first time mothers of a child less than 12 months of age and mothers with more than one child,” Ms Marsh said.

“First time mothers with babies had the most optimal behaviours with antibiotics, this was likely due to these parents having less exposure to using antibiotics and managing childhood illnesses than parents with older and multiple children.”

Access to healthcare also played a significant role in the mother’s decisions to utilise antibiotics with nearly all mothers raising difficulties with their children being seen by a GP in a timely manner.

Ms Marsh’s supervisor Professor Mitchell Byrne said the findings from this research would help inform interventions to reduce the impact of AMR.

“From this study, we now understand the drivers behind parental decisions to give their children antibiotics in rural and remote areas which will help us to formulate a range of primarily educational based interventions,”

The project team which includes CDU Lecturer in Psychology Dr Sara Parsafar, who is co-supervisor, will now look to commence a systemic review of parental decisions regarding antibiotic use in children across the world to assist with the development of interventions.

The study which can be found here.


Contact details:

Emily Bostock
Acting Research Communications Officer

T: +61 8 8946 6529
M: 0432 417 518
E: 
[email protected]

Media

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTANĀ® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.